Related Experiment Video
Updated: Aug 15, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
[A case of hypothyroidism induced by interferon therapy for renal cell carcinoma]
Abstract:
A 54-year-old man, who had undergone left radical nephrectomy due to a renal cell carcinoma 2 years previously, had received adjuvant interferon (IFN) therapy for 2 years. One month has passed after IFN therapy, when he started to complain of muscle pain. The serum FT3 and FT4 levels were lower than normal range. We diagnosed for hypothyroidism induced by IFN therapy, and he was treated with thyroxine. His serum FT3 and FT4 levels were increased after the initiation of the thyroxine therapy. Many reports of hypothyroidism induced by IFN therapy have been found during the treatment for chronic hepatitis. The hypothyroidism induced after IFN therapy of renal cell carcinoma is very rare. It should be brought to attention that IFN therapy induces hypothyroidism not only during treatment period, but also after the treatment. Careful examination after the therapy is mandatory.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Inhibitors of Viral Protein Synthesis

